ST-elevation Myocardial Infarction Clinical Trial
Official title:
The Short- and Long Term Outcomes of Early Routine PCI With the Standard Treatment in Low-intermediate Risk ST-elevation Myocardial Infarction Patients Who Successfully Fibrinolysis.
1. Objective: To evaluate short- and long-term in the STEMI patients who successfully
thrombolysis with early routine and delay percutaneous coronary intervention in
low-intermediate risk patients.
2. Educational/ application advantages: To evaluate the time of early and delay PCI after
received fibrinolysis had an effect to the short- and long-term clinical outcomes in
low- intermediate GRACE risk score patients. No available of randomized controlled
study in these group of the patients.
1.Research design: Intervention trial 1.1 Study domain: STEMI patients who will receive the
fibrinolysis for reperfusion therapy 1.2 Target population: STEMI patients who will receive
the percutaneous coronary intervention after fibrinolysis in Lampang Regional hospital and
Maharaj Nakorn Chiang Mai hospital.
1.3 Study population: STEMI patients who will receive the percutaneous coronary intervention
after fibrinolysis during the year of 2013-2014 at Lampang Regional hospital and Maharaj
Nakorn Chiang Mai hospital
Inclusion criteria:
1. The patients who received the percutaneous coronary intervention after fibrinolysis
2. Adult patients with age more than 18 years old
3. GRACE risk score less than 155 (low-intermediate risk)
Exclusion criteria:
1. The patients who received primary PCI or rescue PCI
2. The patients who had the previous history of coronary-artery bypass surgery
3. The high risk patients (such as cardiogenic shock, complete heart block, GRACE ≥155)
1.4 Occurrence relation Y (Composite outcomes) = f (Treatment early vs. delay | confounders)
1.5 Setting: The study will be conducted in Lampang Regional hospital and Maharaj Nakorn
Chiang Mai hospital.
1.6 Determinant (x): Time to percutaneous coronary intervention (early vs. delayed).
1.7 Events (y): composite outcomes (included of death, re-infarction, and recurrent
ischemia), re-hospitalized with ACS, and worsening heart failure.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01864343 -
Target Temperature Management In Myocardial Infarction - A Pilot Study
|
N/A | |
| Completed |
NCT00962416 -
Comparison of Biomatrix Versus Gazelle in ST-Elevation Myocardial Infarction (STEMI)
|
Phase 4 | |
| Active, not recruiting |
NCT00927615 -
Comparison of Intracoronary Versus Intravenous Abciximab in ST-segment Elevation Myocardial Infarction (CICERO)
|
N/A | |
| Completed |
NCT03135275 -
MULTivessel Immediate Versus STAged RevaScularization in Acute Myocardial Infarction -The MULTISTARS AMI Trial
|
N/A | |
| Recruiting |
NCT02592694 -
Intracoronary Cocktail Injection Combined With Thrombus Aspiration in STEMI Patients Treated With Primary Angioplasty
|
Phase 4 | |
| Withdrawn |
NCT01991366 -
Should Integrilin be an Integral Part of Adjunctive Therapy in Patients Undergoing Primary PCI for ST-Elevation MI?
|
||
| Completed |
NCT02158468 -
Effect of Conditioning on Myocardial Damage in STEMI
|
N/A | |
| Completed |
NCT01197729 -
OPTAMI (Optimized Therapy of Acute Myocardial Infarction) - Registry
|
N/A | |
| Completed |
NCT06426537 -
Colchicine's Efficacy in MI Patients: Comparing PCI and Non-Reperfusion Approaches
|
Early Phase 1 | |
| Completed |
NCT01882179 -
Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size
|
Phase 3 | |
| Terminated |
NCT00719914 -
A Safety/Efficacy Study of Intracoronary Integrilin to Improve Balloon Angioplasty Outcomes for the Treatment of Heart Attacks
|
Phase 2 | |
| Completed |
NCT00952224 -
Myocardial Salvage Assessed by Cardiovascular Magnetic Resonance - Impact on Outcome
|
N/A | |
| Completed |
NCT00378391 -
European Registry on STEMI Patients Transferred for PCI With Upstream Use of Abciximab - EuroTransfer Registry
|
N/A | |
| Withdrawn |
NCT04303377 -
Early Treatment With Evolocumab in Patients With ST-elevation Myocardial Infarction
|
Phase 2 | |
| Completed |
NCT03523624 -
Factor XIII and Other Biomarkers in ST Segment Elevation Myocardial Infarction
|
||
| Completed |
NCT01531114 -
PraSugrel vs TicagrElor in ST-Elevation Myocardial Infarction paTients With Diabetes Mellitus
|
Phase 3 | |
| Active, not recruiting |
NCT01960933 -
Primary PCI in Patients With ST-elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization
|
N/A | |
| Completed |
NCT00502528 -
Endothelin Receptor Blockade in Acute ST-elevation Myocardial Infarction
|
Phase 2 | |
| Recruiting |
NCT02062554 -
Brasilia Heart Study
|
||
| Recruiting |
NCT04150016 -
In-stent Repair and Vessel Reaction of STEMI Patients With OCT
|
N/A |